Nasdaq, Inc.: Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date September 15, 2026

At the end of the settlement date of September 15, 2026, short interest in 3,862 Nasdaq Global MarketSM securities totaled 18 ...

Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act

The Company has filed a Form 25 (Notification of Removal from Listing) with the SEC on September 24, 2026 to remove its Class A Ordinary Shares and Warrants from listing on Nasdaq and to deregister th ...

Fathom Holdings and Neighborhood Intelligence Announce Proposed Restructured Transaction Focused on Real Estate and Digital Assets

Proposed transaction would combine Fathom's national residential brokerage and title business with NXH's interests in tZERO, the Medici portfolio and GrainChain Proposed Transaction would ascribe no ...

District Metals Corp.: District Announces 2026 Year End Results

District Metals Corp. (TSXV: DMX) (Nasdaq First North: DMXSE SDB) (OTCQX: DMXCF) (FSE: DFPP); ("District" or the "Company") is pleased ...

SRX Global Inc: SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)

SRX Global Inc. (NYSE American: SRXH) (the "Company" or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value through ...

1911 Gold Corporation: 1911 Gold Files NI 43-101 Technical Report for the Ogama-Rockland Gold Project Updated Mineral Resource Estimate

Gold Corporation ("1911 Gold" or the "Company") (TSXV: AUMB) (OTCQX: AUMBF) (FRA: 2KY) is pleased to report that following the release of ...

Rezolute, Inc.: Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update

Rezolute, Inc. (Nasdaq: RZLT) ("Rezolute" or the "Company"), a late-stage ultra-rare rare disease company focused on treating refractory hypoglycemia ...

Akamai Technologies, Inc.: Akamai Announces $11.6 Billion Multi-year Agreement with Anthropic to Support Growing Demand

Anthropic to leverage Akamai Cloud's distributed infrastructure and software to support CPU workload growth at scaleThe transaction provides for the potential expansion of the relationship by up to an ...

XtalPi Inc.: XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain

This milestone marks the first IND submission from XtalPi's proprietary pipeline, recently unveiled in its interim results, validating the company's AI and robotics-driven ...

Archimedes Tech SPAC Partners II Co. Announces Effectiveness of Registration Statement and Date for Extraordinary General Meeting to Approve Proposed Business Combination with ...

Extraordinary General Meeting Scheduled for October 16, 2026 Shareholders of Record as of September 1, 2026 are Eligible to Vote at EGM CLAYMONT, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Archimedes Te ...

Prime Medicine, Inc.: Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency

Clearance highlights continued execution, modularity and momentum across Prime Medicine's liver franchise, building on recent regulatory clearances for PM577a -- -- Initial clinical data expected ...

Legacy Education Inc.: Legacy Education Delivers Record Fiscal 2026 Results with 25% Revenue Growth and Continued Enrollment Gains

Legacy Education Inc. ("Legacy Education" or the "Company") (NYSE American: LGCY), a leading provider of career education ...